3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
6
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Breast Neoplasms
470
Neoplasms
328
Colorectal Neoplasms
237
Carcinoma, Non-Small-Cell Lung
232
Lung Neoplasms
202
Prostatic Neoplasms
181
Carcinoma, Hepatocellular
173
Stomach Neoplasms
138
Pancreatic Neoplasms
124
Leukemia, Myeloid, Acute
114
Uterine Cervical Neoplasms
110
Rectal Neoplasms
104
Multiple Myeloma
92
Recurrence
87
Squamous Cell Carcinoma of Head and Neck
84
Head and Neck Neoplasms
78
Neoplasm Metastasis
76
Ovarian Neoplasms
74
Colonic Neoplasms
69
Brain Neoplasms
68
Triple Negative Breast Neoplasms
66
Esophageal Neoplasms
66
Glioblastoma
65
Endometrial Neoplasms
58
Precursor Cell Lymphoblastic Leukemia-Lymphoma
55
Motor Activity
55
Small Cell Lung Carcinoma
54
Disease
54
Hematologic Neoplasms
53
Glioma
47
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
OTHER
×
Erdheim-Chester Disease
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled